undamentalytics Newsletter
Sign in

Maravai Lifesciences Holdings, Inc. revenue

Maravai Lifesciences Holdings, Inc.'s revenue was $186m in fiscal 2025, down 28.3% on the year before. Since fiscal 2019 ($143m) it has grown at a compound 4.4% a year. Over the last twelve months it was $209m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue143284799883289259186209
Growth on the year before—+98.5%+181.3%+10.5%−67.3%−10.3%−28.3%—
Gross profit762046597141401083473
Gross margin53.3%72.0%82.4%80.9%48.5%41.8%18.3%34.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Tri Link $120M 64.5% ▼ 39.0%
Cygnus $66M 35.5% ▲ 5.0%
Geography
Region Revenue Share YoY
North America $112M 60.8% ▼ 11.6%
United States $111M 98.7% ▼ 10.3%
Latin and Central America $971,000 0.9% ▲ 46.7%
Asia Pacific $41.5M 22.4% ▼ 53.6%
EMEA $30.9M 16.7% ▼ 26.5%

From Maravai Lifesciences Holdings, Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Maravai Lifesciences Holdings, Inc. $209m -5.0% -27.3%
Cytek Biosciences, Inc. $207m 5.4% 5.6%
Cryoport, Inc. $186m 12.1% -8.2%
Mesa Laboratories Inc $250m 3.0% 4.4%
Schrodinger, Inc. $259m 8.9% 10.2%
Grail, Inc. $165m 23.1% —

Compare with peers

Head to head: CTKB vs MRVICYRX vs MRVIMLAB vs MRVIMRVI vs SDGR

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Maravai Lifesciences Holdings, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Maravai Lifesciences Holdings, Inc.